April 17, 2008 10:03 ET

Ceapro Licenses New Mint Variety: Will Develop Extracts for Innovative Cosmeceuticals and Nutraceuticals

EDMONTON, ALBERTA, CANADA--(Marketwire - April 17, 2008) - Ceapro Inc. (TSX VENTURE:CZO) has signed a licensing agreement with the University of Guelph for the use of a spearmint variety containing very high levels of rosmarinic acid, a powerful antioxidant and anti-inflammatory. Generally the compound is found only in limited quantities - most typically in rosemary but also in smaller quantities in several herbal plant species, including mint. The appeal for Ceapro is threefold:

- Mint is a natural ingredient, fitting in well with Ceapro's organic production of extracts and products.

- Unlike its eponymous source, rosmarinic acid extracted from mint can be colourless and flavourless, making it a superlative active ingredient for inclusion in cosmeceuticals and nutraceuticals, and also allowing Ceapro to satisfy the market demand for innovation.

- Mint is a hearty and fecund plant: up to three crops can be harvested per year even in Canada's challenging climate, making it a cost-effective source of rosmarinic acid.

Ceapro will apply its patented extraction and processing technologies to create products with cosmeceutical, nutraceutical and pharmaceutical applications. "This is a very important opportunity for us," said Ceapro CEO Mark Redmond. "We expect our growing distributor network will find broad market appeal and acceptance for a rosmarinic acid that is odourless, tasteless and ingestible. This moves Ceapro's natural product offerings beyond organics and into nutraceuticals."

Steve De Brabandere, Technology Transfer Manager at University of Guelph added, "We are excited to be working with a rising Canadian company experienced in the extraction and marketing of natural health products. We're confident that Ceapro will enable this innovation to reach a wide market."

Other Nutraceutical News

Ceapro representatives will be in Geneva from 6 to 8 May 2008 for the Vitafoods International Conference. The Conference has an international reputation within the nutraceuticals industry for delivering a program that covers the hottest topics and themes in food ingredients. The conference attracts some of the leading industry figures to share their latest findings and discoveries. Visit Ceapro at Stand 755. A nutraceutical is defined as any substance that is a food or part of a food and provides medical or health benefits, including the prevention and treatment of disease (DeFelice 1994).

About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company whose primary business activities relate to the development and commercialization of organic products for medical, cosmetic and animal health industries using proprietary technology and natural, renewable resources. We will also be applying our technology to become an active participant in the bio-energy sector. We have introduced health and wellness services employing our CeaProve® diagnostic technology. To learn more about Ceapro, visit www.ceapro.com

The TSX has neither approved nor disapproved of the information contained herein. This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Contact Information

  • Ceapro Inc.
    Dr. Mark Redmond
    President and CEO
    T (Edmonton): 780-421-4555
    Sun International Communications
    Nicole Blanchard, B.Sc., B.Comm.
    Managing Partner
    T (Montreal): 450-973-6600